logo
BREAKING NEWS Nevada rocked by earthquake swarm with the strongest reaching nearly 5 magnitude

BREAKING NEWS Nevada rocked by earthquake swarm with the strongest reaching nearly 5 magnitude

Daily Mail​06-06-2025
Nevada has experienced an uptick in seismic activity over the last 24 hours.
The US Geological Survey (USGS) detected seven earthquakes, with the largest measuring a 4.8 magnitude, that hit at 7:16am ET near Caliente.
The other tremors, starting Thursday and continuing into Friday, ranged from 1.1 magnitude to 3.3 magnitude.
The 4.8 magnitude is the latest earthquake to hit, with shaking detected as far south as Las Vegas, which sits more than 150 miles south.
It was likely caused by tectonic activity along one of the many fault systems in the Basin and Range Province, a region known for stretching and thinning of the Earth's crust.
The USGS detect a 3.3 magnitude earthquake Thursday about 14 miles northeast of Nellis Air Force Base. This was followed by two smaller tremors just minutes later.
Nellis Air Force Base tested US nuclear weapons above ground during the 1950s and 1960s, but testing moved underground until all operations ceased in 1992.
Nevada is the nation's third-most seismically active state, ranking behind only California and Alaska.
This is a developing story... More updates to come
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Scientists study snail that can grow its eyes back in hope of helping humans with eye injuries
Scientists study snail that can grow its eyes back in hope of helping humans with eye injuries

The Independent

time12 minutes ago

  • The Independent

Scientists study snail that can grow its eyes back in hope of helping humans with eye injuries

Scientists are studying a type of snail that can grow its eyes back in the hope of helping humans with eye injuries. The complex structure of humans eyes has been found to be similar to those of the freshwater apple snail, which can entirely regenerate its eyes. A new study showed that the eyes of both have many anatomical and genetic features in common. Researchers are now studying how the regrowth is possible in the snails, with the aim of eventually restoring the vision of people who have eye injuries. They have created ways to edit the snail's genome, enabling them to look at the genetic and molecular mechanisms driving eye regeneration. Alice Accorsi, assistant professor of molecular and cellular biology at the University of California, Davis, who led the team, said: 'Apple snails are an extraordinary organism. They provide a unique opportunity to study regeneration of complex sensory organs. Before this, we were missing a system for studying full eye regeneration.' A freshwater snail species originating in South America, the golden apple snail (Pomacea canaliculata) is now invasive in many other places around the world. However, Ms Accorsi said it is the exact traits that make the animals so invasive, which make them ideal to experiment with in the lab. 'Apple snails are resilient, their generation time is very short, and they have a lot of babies,' she said. As well as being straightforward to grow, apple snails have 'camera-type' eyes, which produce especially high-resolution images – and are the same type that humans have. And snails, in general, are also known for their regenerative abilities. 'When I started reading about this, I was asking myself, why isn't anybody already using snails to study regeneration?' questioned Ms Accorsi, who is the first person to do so. 'I think it's because we just hadn't found the perfect snail to study, until now. A lot of other snails are difficult or very slow to breed in the lab, and many species also go through metamorphosis, which presents an extra challenge.' The study, published in Nature Communications, showed the similarities between the apple snails' and human eyes via dissections, microscopy and genomic analysis conducted by the team. Ms Accorsi said: 'We did a lot of work to show that many genes that participate in human eye development are also present in the snail. After regeneration, the morphology and gene expression of the new eye is pretty much identical to the original one.' The researchers then outlined the regrowth process of the snails' eyes following amputation. They explained: 'First, the wound must heal to prevent infection and fluid loss, which usually takes around 24 hours. Then, unspecialized cells migrate and proliferate in the area. Over the course of about a week and a half, these cells specialize and begin to form eye structures including the lens and retina. By day 15 post-amputation, all of the eye's structures are present, including the optic nerve, but these structures continue to mature and grow for several more weeks.' However, even though the team know the apple snails have all the components required to form images, the team are still working on finding out if the animals can actually see. The researchers are also editing the snails' genome using CRISPR-Cas9 in attempts to understand how genes regulate regeneration. 'The idea is that we mutate specific genes and then see what effect it has on the animal, which can help us understand the function of different parts of the genome,' said Ms Accorsi. 'If we find a set of genes that are important for eye regeneration, and these genes are also present in vertebrates, in theory we could activate them to enable eye regeneration in humans.'

Breakthrough study finds Alzheimer's could be due to this deficiency
Breakthrough study finds Alzheimer's could be due to this deficiency

The Independent

time2 hours ago

  • The Independent

Breakthrough study finds Alzheimer's could be due to this deficiency

A deficiency of the metal lithium in the body could be a key factor contributing to the development of dementia in Alzherimer's patients, a groundbreaking new study reveals. The decade-long research, published in the journal Nature, shows for the first time that lithium occurs naturally in the brain and maintains the normal function of all its major cell types, preventing nerves from degradation. Scientists from Harvard Medical School found that lithium loss in the human brain is one of the earliest changes leading to Alzheimer's, while in mice, a similar lithium depletion accelerated memory decline. A reduced lithium level was found in some cases due to the metal's impaired uptake and its binding to amyloid plaques, which are known to be smoking gun signs of Alzheimer's. Researchers also showed that a new type of lithium compound – lithium orotate – can avoid capture by amyloid plaques and restore memory in mice. In the study, scientists used an advanced type of mass spectroscopy chemical analysis method to measure trace levels of about 30 different metals in the brain and blood samples from a range of people, including cognitively healthy people, those in an early stage of dementia, and those with advanced Alzheimer's. The analysis revealed that lithium was the only metal with markedly different levels across groups, which also seemed to change at the earliest stages of memory loss. 'Lithium turns out to be like other nutrients we get from the environment, such as iron and vitamin C,' study senior author Bruce Yankner said. 'It's the first time anyone's shown that lithium exists at a natural level that's biologically meaningful without giving it as a drug,' Dr Yankner said. Although lithium compounds have been historically in use to treat a range of mental conditions like bipolar disorder and major depressive disorder, in these cases, they are given at much higher concentrations that could even be toxic to older people. Scientists have now found that lithium orotate is effective at one-thousandth this dose – enough to mimic the natural level of lithium in the brain. The latest findings with lithium orotate, however, needs to be confirmed in humans via clinical trials. Yet, researchers suspect that measuring lithium levels could help screen people for early Alzheimer's. The findings revise the theory of Alzheimer's disease, which affects nearly 400 million people worldwide, offering a new strategy for early diagnosis, prevention, and treatment. Decades of studies have shown that Alzheimer's disease involves an array of brain abnormalities, including clumps of the protein amyloid beta, tangles of the protein tau, and a loss of the brain's protective protein REST. However, these abnormalities have never fully explained the condition. For instance, it remains unclear why some people with Alzheimer's-like changes in the brain never go on to develop dementia or cognitive decline. Recent treatments developed to target amyloid beta plaques also don't seem to reverse memory loss, only modestly reducing the rate of cognitive decline. Now, scientists say lithium could be the critical missing link. 'The idea that lithium deficiency could be a cause of Alzheimer's disease is new and suggests a different therapeutic approach,' Dr Yankner said. 'You have to be careful about extrapolating from mouse models, and you never know until you try it in a controlled human clinical trial... But so far the results are very encouraging,' he added.

US rejection of mRNA vaccines shows ‘lack of respect for science,' says Nobel laureate
US rejection of mRNA vaccines shows ‘lack of respect for science,' says Nobel laureate

Telegraph

time2 hours ago

  • Telegraph

US rejection of mRNA vaccines shows ‘lack of respect for science,' says Nobel laureate

The Nobel Prize winning scientist behind mRNA vaccine technology has attacked the US health secretary's plan to effectively cancel the use and development of the science in America. Speaking exclusively to The Telegraph, Dr Katalin Karikó, said the decision by Robert F Kennedy Jr to cancel $500 million worth of mRNA research and development contracts is 'devastating' and reflects a 'lack of respect for science.' Dr Karikó, who received the Nobel Prize in 2023 for her groundbreaking work on messenger RNA, the technology behind the Pfizer and Moderna Covid-19 vaccines, added the decision could have far-reaching consequences. 'The global progress of vaccine development and science is suffering because of this decision and others like it affecting scientific enterprise in the United States,' she said. 'If you are sick, you don't ask your lawyer what to do. RFK Jr. is a lawyer who doesn't understand these issues. You ask a physician, someone knowledgeable on the subject,' Dr Karikó added. Mr Kennedy, an outspoken vaccine sceptic, announced on Tuesday that federal funding for at least 22 major mRNA vaccine contracts with companies including Moderna, Pfizer, and CSL Seqirus would be terminated. He said the Department of Health and Human Services (HHS) would redirect funding toward 'safer, broader vaccine platforms that remain effective even as viruses mutate'. The health secretary also claimed the mRNA platform 'fails to protect effectively against upper respiratory infections like Covid and flu,' though he offered no scientific evidence to support the assertion. The technology was first deployed globally during the Covid-19 pandemic and is widely credited with saving millions of lives. While traditional vaccines use inactivated fragments of viruses to prompt an immune response, mRNA vaccines do not contain any part of the actual virus. Instead, they deliver genetic instructions to spark a response. The main advantage of mRNA vaccines is that they can be designed and manufactured much more quickly than traditional vaccines. Flu vaccines, for example, are typically grown in chicken eggs – an arduous process that can take months. In contrast, the mRNA platform can be adapted to match a pandemic-causing pathogen within just a few days. Mr Kennedy alleged that mRNA vaccines 'encourage new mutations and can actually prolong pandemics,' suggesting they force viruses to evolve to escape vaccine-induced immunity, a claim that scientists strongly dispute. 'No vaccine, including mRNA, encourages new mutations,' said Professor Stephen Evans, Emeritus Professor of Pharmacoepidemiology at the London School of Hygiene and Tropical Medicine. 'Mutations occur randomly during viral replication. When a virus spreads easily, mutations are more likely. An effective vaccine suppresses viral replication, reducing the chance of mutation. In that sense, vaccines actually discourage new variants,' Prof Evans said. Alex Pym, Director of Infectious Disease at the Wellcome Trust added: 'mRNA vaccine technology has been in development for decades. It has been shown to be safe and effective against infectious diseases.' In May, Mr Kennedy cancelled a $766 million contract with Moderna for the development of mRNA human bird flu vaccine. The pharmaceutical giant was awarded the multi-million dollar contract by the Biden administration last year, as the H5N1 virus began to ravage US dairy and poultry farms. In the same month, he also announced that mRNA Covid vaccines would no longer be recommended for healthy children or healthy pregnant women.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store